Robert N. Weingarten - 30 Jun 2023 Form 4 Insider Report for Guardion Health Sciences, Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 30 Jun 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Jul 2023, 17:00:46 UTC
Prior SEC filing: 09 Nov 2022
Source filing: View source filing
Reporting owner signature: /s/ Robert Weingarten

Key filing fact

Robert N. Weingarten filed Form 4 for Guardion Health Sciences, Inc. on 05 Jul 2023.

Key facts

This page summarizes Robert N. Weingarten's Form 4 filing for Guardion Health Sciences, Inc..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 05 Jul 2023, 17:00.

Change

Previous filing in this sequence was filed on 09 Nov 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GHSI transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +334
Change %
Price: $0.000000
Shares after: 334
Date: 30 Jun 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 334
Exercise price: $7.78
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option shall vest and become exercisable in eight equal installments on the last day of each of the subsequent eight calendar quarter-end dates following the date of grant (the first of such dates being September 30, 2023), subject to continued service on each vesting date.